Stocks · Health care · Pharmaceutical Preparations

Corbus Pharmaceuticals Holdings, Inc.

CRBP Clue Score27
United States Fiscal year ends December CIK 0001595097 Results filed 6 Aug 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Alan F Holmer
14 Jun 2024
Director
Exercised, kept
1,667
$30.00
$50.01K
Sean F. Moran
10 Apr 2024
Chief Financial Officer
Exercised, kept
1,787
$30.00
$53.61K
Yuval Cohen
26 Jan 2024
Chief Executive Officer
Exercised, kept
7,179
$4.97
$35.68K
Alan F Holmer
26 Jan 2024
Director
Exercised, kept
629
$4.97
$3.13K
Mark Tepper
14 Nov 2018
President and CSO
Exercised, kept
10,000
$1.00
$10.00K
Yuval Cohen
16 Mar 2017
Chief Executive Officer
Exercised, kept
20,000
$1.00
$20.00K

What was left out

Form 4 filings counted 216
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 6
Sales on a Rule 10b5-1 plan 12
Sales straight out of an exercise 19
Sales at will 7
Transactions with no price 0
Shares from compensation/vesting 1,398,906
History held since 26 Nov 2014